IRONWOOD PHARMA INC CLASS A (IRWD)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for IRWD
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| IRWD | Founder and Co-Chief Executive Officer, Acelyst Consulting, LLC | 56 | ["Founder and Co-Chief Executive Officer at Acelyst Consulting LLC","Chief marketing officer of Datavant, Inc.","Chief customer officer of Aetion, Inc.","Advisor to the chief executive officer of IQVIA Holdings Inc.","Senior vice president for strategy, marketing and communications for IQVIA","Vice president for global services marketing and knowledge management at IQVIA","Regional leader of the IMS Consulting Group in Europe","Location manager for the London IMS Consulting Group","Senior principal at IMS Consulting Group","Led several marketing efforts for Pfizer Inc.","Consulted for McKinsey & Company","B.S. in economics from Arizona State University","M.B.A. from the Fuqua School of Business at Duke University","Expertise in strategic marketing, evidence-based research and customer experience in the life science industry"] | ["Compensation and HR Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Founder and Co-Chief Executive Officer, Acelyst Consulting, LLC Age: 56 Director since 2019 Board Committees Compensation and HR Committee Ms. Kessler is founder and Co-Chief Executive Officer at Acelyst Consulting LLC, a business consulting and service provider company, since April 2024. Prior to joining Acelyst Consulting LLC, Ms. Kessler served as chief marketing officer of Datavant, Inc., a health IT company, from October 2022 to April 2024 and as chief customer officer of Aetion, Inc., a health care technology company, from September 2021 to October 2022. Before that, Ms. Kessler served as an advisor to the chief executive officer of IQVIA Holdings Inc., or IQVIA (formerly IMS Health and Quintiles), a global analytics and technology company, from October 2020 to February 2021 and previously she had been the senior vice president for strategy, marketing and communications for IQVIA since October 2016. Previously, Ms. Kessler served in various roles for IQVIA, including vice president for global services marketing and knowledge management from 2013 to 2016, regional leader of the IMS Consulting Group in Europe from 2011 to 2013, location manager for the London IMS Consulting Group from 2009 to 2011 and senior principal from 2008 to 2009. Before joining IQVIA, Ms. Kessler led several marketing efforts for Pfizer Inc. from 2004 to 2007 and worked in consulting for McKinsey & Company from 1996 to 2004. Ms. Kessler received a B.S. in economics from Arizona State University and an M.B.A. from the Fuqua School of Business at Duke University. Ms. Kessler provides an important commercial perspective to our board of directors given her expertise in strategic marketing, evidence-based research and customer experience in the life science industry.